Pharmacogenomics: the promise of personalized medicine for CNS disorders.
about
Biomarkers predicting antidepressant treatment response: how can we advance the field?Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?Personalized medicine in psychiatry: problems and promises.mRNA transcripts as molecular biomarkers in medicine and nutrition.A pathway to personalization of integrated treatment: informatics and decision science in psychiatric rehabilitation.Drug development in pediatric psychiatry: current status, future trends.Predictors of lithium response in bipolar disorder.Tracking the impact of translational research in psychiatry: state of the art and perspectivesResting-state connectivity predictors of response to psychotherapy in major depressive disorder.Pharmacogenetics in heart failure: promises and challenges.Issues surrounding the health economic evaluation of genomic technologies.(13)C breath tests in personalized medicine: fiction or reality?Towards personalizing treatment for depression : developing treatment values markers.The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.Shared decision making in mental health: prospects for personalized medicine.Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Pharmacogenetics in psychiatry: translating research into clinical practice.Gene × environment interactions in the prediction of response to antidepressant treatment.The implications of genomics on the nursing care of adults with neuropsychiatric conditions.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Looking to the future of research in pediatric anxiety disorders.Blood glutathione peroxidase-1 mRNA levels can be used as molecular biomarkers to determine dietary selenium requirements in rats.Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank.What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?Pharmacogenomics in practice: a case report of personalized inpatient psychiatric care.Ethical Responsibilities and Perceptions of Stakeholders of Genetic Research Involving Racial/Ethnic Minority Participants
P2860
Q27026147-087402AC-B914-4798-BE51-ED48D3BBA482Q31153904-4B8273AC-A2CF-4F1B-824D-D4ACCABA87BAQ33626990-0C5F11A3-D3B6-40A6-92F1-6753AC782907Q34726454-6AD50A13-4B8A-4C32-9497-9762F3313560Q34983191-6201E395-21B7-4DE7-A304-58FC72ABAC35Q35176777-113D8747-0874-4E0F-BAE7-6A86270DCA6AQ35811894-18AC445B-5769-4C6F-BCCB-BA97DF238D1FQ36443736-2C97B2D9-EF8C-4515-B7B9-3DF8D1C67190Q36498636-E3EC8A79-DFBC-454B-B18C-0E471D0FD6A8Q37024826-0A948443-B3DC-4B86-A0C7-2956430497D6Q37532571-8509C8DC-C04E-4B0E-8854-4230536D2D3AQ37541151-D9539956-4544-4BCC-9025-1589D38D9961Q37628680-B30539FD-0E67-4B5E-BC22-7368291666EDQ37630855-4324290B-21E8-4C0E-ACD8-BF5ADB77AA9FQ37687997-F5150222-7825-4804-B1F2-37F7911427CEQ37688001-3131FEF3-D5D6-4B8C-AFC1-20777340EB91Q37848476-750FAF9E-A965-4384-AD4D-E1CC03722568Q37926893-E92FE197-1E1A-4414-91D0-022084921AA5Q37956206-C3B47078-078C-41B2-B7C6-90ECA6D964CEQ38067101-FEC2135B-B885-4B85-A467-358B0A7EA5FDQ38078013-3FC1602F-98F2-45B0-ADE4-A913D8FE516CQ38154911-7DEAE19A-3036-43FD-9577-C7CF7CC8551CQ39804940-C573DC30-9F92-4D1D-88EE-67D525B3C1BFQ43255369-0B7A9803-31E6-4391-87BA-2A237680453FQ43450643-DC086048-77E6-43BC-AF47-D6DD901F224FQ46639562-7AB826A6-9A88-4431-BB69-AD9252A10AC9Q48084461-1CBAE5CB-17F8-40F3-BC36-26CD2CD6DD07Q58133143-4FA4BBFD-3494-4DD9-8101-9CF4694FD528
P2860
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@en
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@nl
type
label
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@en
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@nl
prefLabel
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@en
Pharmacogenomics: the promise of personalized medicine for CNS disorders.
@nl
P2860
P356
P1476
Pharmacogenomics: the promise of personalized medicine for CNS disorders
@en
P2093
Jose de Leon
P2860
P2888
P304
P356
10.1038/NPP.2008.147
P407
P50
P577
2008-09-17T00:00:00Z